Log in

Relevant bibliographies by topics / COVID-19 SYNDROME / Journal articles

To see the other types of publications on this topic, follow the link: COVID-19 SYNDROME.

Journal articles on the topic 'COVID-19 SYNDROME'

Author: Grafiati

Published: 5 June 2025

Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'COVID-19 SYNDROME.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Smykiewicz, Jolanta, Jakub Buczkowski, Marek Mirowski, and Ryszard Tomasiuk. "Post-COVID-19 syndrome and post-COVID-19 vaccination syndrome." Medical Research Journal 10, no. 1 (2025): 1–3. https://doi.org/10.5603/mrj.101813.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Galstyan, G. M. "Coagulopathy in COVID-19." PULMONOLOGIYA 30, no. 5 (2020): 645–57. http://dx.doi.org/10.18093/0869-0189-2020-30-5-645-657.

Full text

Abstract:

Hemostatic disorders play an important role in the pathogenesis and clinical manifestations of COVID-19. The purpose of the research was a detailed consideration of the pathogenesis, clinical manifestations, and methods of diagnosing and treatment of coronavirus-induced coagulopathy (CIC). At the onset of COVID-19, hypercoagulability is detected, and consumption coagulopathy and disseminated intravascular coagulation (DIC) syndrome are usually observed at later stages of the disease. In the pathogenesis of hypercoagulation in patients with COVID-19, proinflammatory cytokines, hyperfibrinogenem

APA, Harvard, Vancouver, ISO, and other styles

3

Asfandiyarova, N. S. "Post-COVID-19 syndrome." Clinical Medicine (Russian Journal) 99, no. 7-8 (2022): 429–35. http://dx.doi.org/10.30629/0023-2149-2021-99-7-8-429-435.

Full text

Abstract:

The disease caused by new coronavirus infection (COVID-19) is a global problem not only because of its wide spread occurrance, but also due to the high incidence of post-COVID syndrome. The literature review presents the results of numerous observations of patients, who undergone COVID-19. The most common symptoms are: general weakness, impaired cognitive functions, memory loss, depression, anosmia, dysgeusia, shortness of breath, cough, chest pain, abdominal pain, anorexia, nausea, vomiting, diarrhea, less often — alopecia, skin rashes, etc. The most frequent symptoms of the post-COVID syndro

APA, Harvard, Vancouver, ISO, and other styles

4

Cha, Jae Myung. "Post-COVID-19 Syndrome." Korean Journal of Medicine 97, no. 5 (2022): 284–91. http://dx.doi.org/10.3904/kjm.2022.97.5.284.

Full text

Abstract:

Although acute COVID-19 usually lasts for 12 weeks from the onset of symptoms, some patients experience variable persistent symptoms. Post-COVID-19 syndrome is defined as persistent symptoms and/or long-term complications that appear during or after COVID-19, persist for more than 12 weeks, and cannot be explained by an alternative diagnosis. The common symptoms of post-COVID-19 syndrome include general, pulmonary, hematological, cardiovascular, neuropsychiatric, renal, endocrine, gastroenterological, and dermatological symptoms. As the natural course and pathophysiology of COVID-19 are not ye

APA, Harvard, Vancouver, ISO, and other styles

5

Jaramillo-Acosta, MA Ramírez-Salgado CA Castillo Narvaez NA Rahman Md M. "Post-COVID Syndrome: Changing the Prognosis of Chronic Non-communicable Diseases." J Biomed Res Environ Sci 3, no. 4 (2022): 391–92. https://doi.org/10.37871/jbres1453.

Full text

Abstract:

Post-COVID-19 syndrome is defined as the persistence of signs or symptoms following the acute phase of COVID-19 [1], which may persist for an indeterminate period of time; or it is defined as the period of risk following the acute phase of COVID-19 [1], in which major complications may occur depending on organ injury during the first phase of COVID-19 [1-3].

APA, Harvard, Vancouver, ISO, and other styles

6

Pierce, Janet D., Qiuhua Shen, Samantha A. Cintron, and John B. Hiebert. "Post-COVID-19 Syndrome." Nursing Research 71, no. 2 (2022): 164–74. http://dx.doi.org/10.1097/nnr.0000000000000565.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Natoli, Valentino, Vincenzo Natoli, and Antonella Rosa Longo. "Post-COVID-19 Syndrome." Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) 7, no. 1 (2024): 240–41. http://dx.doi.org/10.54133/ajms.v7i1.1361.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Kamath, Vasantha, R. Anand, Buvana Radhakrishnan, and Kushal Markanday. "Post-COVID-19 syndrome." APIK Journal of Internal Medicine 11, no. 2 (2023): 70. http://dx.doi.org/10.4103/ajim.ajim_119_21.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Nick, Bakalis, Andreou Aikaterini, Varzelioti Niki, Michalopoulou Antigone, Albani Eleni, and Filiotis Nikolaos. "Mobbing Syndrome during COVID-19." INTERNATIONAL JOURNAL OF MEDICAL SCIENCE AND CLINICAL RESEARCH STUDIES 02, no. 06 (2022): 498–504. https://doi.org/10.5281/zenodo.6655414.

Full text

Abstract:

Introduction: Mobbing syndrome is frequently observed in health care settings. Inadequate management has a profound effect on victims since they demonstrate difficulties in defending themselves while causing them physical, psychological, social and work-related consequences. Aim: To measure the occurrence of this phenomenon among nursing staff in the midst of a covid-19 pandemic. Methodology: The Negative Acts Questionnaire- Revised (NAQ-R), an instrument designed to measure exposure to bullying in the workplace was used. It consisted of a total of 31 questions. Chrobanch alpha reliability coe

APA, Harvard, Vancouver, ISO, and other styles

10

Mihajlović, Miroslav, Bogdan Marković, Milan Marinković, Nebojša Mujović, and Tatjana Potpara. "Long COVID-19 syndrome: An overview." Medicinski podmladak 74, no. 4 (2023): 26–34. http://dx.doi.org/10.5937/mp74-47797.

Full text

Abstract:

The Long COVID-19 syndrome has emerged as global epidemic, affecting individuals after an acute infection caused by the Severe acute respiratory syndrome coronavirus 2, impacting multiple organs, including the heart. The most common symptoms encompass fatigue and shortness of breath, which could persist for months after an acute COVID-19 infection. Numerous studies have researched the pathophysiology of Long COVID-19 syndrome, suggesting that local tissue damage and hyperinflation could be employed as possible mechanisms of Long COVID-19 syndrome. Many blood biomarkers (blood urea nitrogen, D-

APA, Harvard, Vancouver, ISO, and other styles

11

Kim, Youn Jeong. "COVID-19 and Long-Term Sequelae." Korean Journal of Medicine 97, no. 1 (2022): 23–27. http://dx.doi.org/10.3904/kjm.2022.97.1.23.

Full text

Abstract:

After acute corona virus disease 2019 (COVID-19), there have been increasing reports of persistent and long-term symptoms similar to the post- viral syndromes described in survivors of severe acute respiratory syndrome (SARS) or middle east respiratory syndrome (MERS). Here, we provide a comprehensive review of the current literature on long-term COVID-19 focusing on organ-specific sequelae. Many of the recovered COVID-19 patients may be affected by long-term health. The future for COVID-19 survivors remains uncertain, and well conducted long term research will be needed.

APA, Harvard, Vancouver, ISO, and other styles

12

Tane, Misato, Hideki Kosako, Takashi Sonoki, and Hiroki Hosoi. "TAFRO Syndrome and COVID-19." Biomedicines 12, no. 6 (2024): 1287. http://dx.doi.org/10.3390/biomedicines12061287.

Full text

Abstract:

TAFRO syndrome is a systemic inflammatory disease characterized by thrombocytopenia and anasarca. It results from hyperinflammation and produces severe cytokine storms. Severe acute respiratory syndrome coronavirus 2, which led to the coronavirus disease 2019 (COVID-19) pandemic, also causes cytokine storms. COVID-19 was reported to be associated with various immune-related manifestations, including multisystem inflammatory syndrome, hemophagocytic syndrome, vasculitis, and immune thrombocytopenia. Although the pathogenesis and complications of COVID-19 have not been fully elucidated, the path

APA, Harvard, Vancouver, ISO, and other styles

13

Čivrná, Jana, Daniela Skanderová, Jiří Ehrmann, and Radovan Pilka. "HELLP syndrome and HELLP-like syndrome in pregnancies with covid-19 – case reports." Česká gynekologie 86, no. 4 (2021): 236–41. http://dx.doi.org/10.48095/cccg2021236.

Full text

Abstract:

Summary: Objective: We present two case reports of severe course of covid-19 in pregnancy demonstrating similarity between covid-19 and HELLP syndrome. Case report: The fi rst case report describes an asymptomatic course of covid-19 accompanied by elevation of liver enzymes and lactate dehydrogenase but low ratio of angiogenic bio markers. No severe pregnancy complication occurred. All laboratory results had normalized after recovering from covid-19. The second case report describes a patient with elevated liver enzymes and lactate dehydrogenase which preceded a respiratory failure. Furthermor

APA, Harvard, Vancouver, ISO, and other styles

14

Greenland, John R., Marilyn D. Michelow, Linlin Wang, and Martin J. London. "COVID-19 Infection." Anesthesiology 132, no. 6 (2020): 1346–61. http://dx.doi.org/10.1097/aln.0000000000003303.

Full text

Abstract:

Abstract Healthcare systems worldwide are responding to Coronavirus Disease 2019 (COVID-19), an emerging infectious syndrome caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus. Patients with COVID-19 can progress from asymptomatic or mild illness to hypoxemic respiratory failure or multisystem organ failure, necessitating intubation and intensive care management. Healthcare providers, and particularly anesthesiologists, are at the frontline of this epidemic, and they need to be aware of the best available evidence to guide therapeutic management of patients with C

APA, Harvard, Vancouver, ISO, and other styles

15

ÇANGA, Aytun. "Covid-19’da Geç Dönem Kardiyovasküler Olaylar." Yüksek İhtisas Üniversitesi Sağlık Bilimleri Dergisi 3, no. 1 (2022): 21–25. http://dx.doi.org/10.51261/yiu.2022.00043.

Full text

Abstract:

Late Cardiovascular Events in Covid-19 ABSTRACT Post-Acute COVID-19 Syndrome (PACS) is defined by persistent symptoms >3–4 weeks after onset of COVID-19. The mechanism of these persistent symptoms is distinct from acute COVID-19 although not completely under-stood despite the high incidence of PACS. Cardiovascular symptoms such as chest pain and palpitations commonly occur in PACS, but the underlying cause of symptoms is infrequently known. While autopsy studies have shown that the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) rarely causes direct myocardial injury, several s

APA, Harvard, Vancouver, ISO, and other styles

16

Verdecchia, Paolo, Claudio Cavallini, Antonio Spanevello, and Fabio Angeli. "COVID-19." Hypertension 76, no. 2 (2020): 294–99. http://dx.doi.org/10.1161/hypertensionaha.120.15353.

Full text

Abstract:

Diffuse pulmonary inflammation, endothelial inflammation, and enhanced thrombosis are cardinal features of coronavirus disease 2019 (COVID-19), the disease caused by the severe acute respiratory syndrome coronavirus 2. These features are reminiscent of several adverse reactions triggered by angiotensin II and opposed by angiotensin 1-7 , in many experimental models. Severe acute respiratory syndrome coronavirus 2 binds to ACE2 (angiotensin-converting enzyme 2) receptors and entries into the cell through the fusion of its membrane with that of the cell. Hence, it downregulates these receptors.

APA, Harvard, Vancouver, ISO, and other styles

17

Evcik, Deniz. "Musculoskeletal involvement: COVID-19 and post COVID 19." Turkish Journal of Physical Medicine and Rehabilitation 1, no. 1 (2023): 1–7. http://dx.doi.org/10.5606/tftrd.2023.12521.

Full text

Abstract:

The worldwide pandemic of coronavirus disease 2019 (COVID-19) was known to predominantly affect the lungs, but it was realized that COVID-19 had a large variety of clinical involvement. Cardiovascular, gastrointestinal, neurological, and musculoskeletal systems are involved by direct or indirect mechanisms with various manifestations. The musculoskeletal involvement can manifest during COVID-19 infection, due to medications used for the treatment of COVID-19, and in the post/long COVID-19 syndrome. The major symptoms are fatigue, myalgia/arthralgia, back pain, low back pain, and chest pain. Du

APA, Harvard, Vancouver, ISO, and other styles

18

O’Keefe, Louise C. "Post-Acute COVID 19 Syndrome, ‘Long COVID’." Workplace Health & Safety 71, no. 5 (2023): 263. http://dx.doi.org/10.1177/21650799231164605.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Ahmed, M. Abbas1 2* Fatma M. Helbawi3 and Mostafa H. Abdelsalam2 4. "Treatment of People with Evans Syndrome in the Setting of COVID-19 Pandemic." Journal of Biomedical Research & Environmental Sciences 1, no. 5 (2020): 160–62. https://doi.org/10.37871/jbres1137.

Full text

Abstract:

A new type of pneumonia had developed from Wuhan Province in China in December 2019, caused by a novel member of the Coronaviridae family named Severe Acute Respiratory Coronavirus 2 Syndrome (SARS-CoV-2) [1]. The disease is characterized by fatigue, dry cough, fever, and dyspnea [2]. In a more severe case, the picture may become more complicated by the onset of interstitial pneumonia with alveolar damage, which clinically can lead to severe Acute Respiratory Distress Syndrome (ARDS) and even death [3]. Since the initial outbreak, the epidemic has had a rapid global spread worldwide, which led

APA, Harvard, Vancouver, ISO, and other styles

20

Grigorieva, K. N., V. O. Bitsadze, J. Kh Khizroeva, et al. "Macrophage activation syndrome in COVID-19." Obstetrics, Gynecology and Reproduction 15, no. 3 (2021): 313–20. http://dx.doi.org/10.17749/2313-7347/ob.gyn.rep.2021.217.

Full text

Abstract:

The novel coronavirus epidemic is characterized by high rates of morbidity and relatively high mortality. Laboratory test results in patients include leukopenia, an increase in liver function tests and ferritin levels reaching hundreds, and sometimes thousands of units. These data remind us about the macrophage activation syndrome (MAC). Secondary hemophagocytic lymphohistiocytosis syndrome, MAC, which pathogenesis is based on a defect in the mechanisms of T-cell cytotoxicity and decreased level of natural killer cells associated with the defect in the perforin-encoding gene as well as hyperpr

APA, Harvard, Vancouver, ISO, and other styles

21

Abdulrauf, Alshawish1* Abubaker Elmaryul2 Aboujela Allafi1 Halima Buni3. "Persistence of Post- COVID-19 Symptoms in Patients Attending Maitiga Preventive Medicine Center in Tripoli, Libya." Alq J Med App Sci 5, no. 2 (2022): 488–92. https://doi.org/10.5281/zenodo.7156702.

Full text

Abstract:

<strong>Background and aims.</strong> Post-acute sequelae of COVID-19 is being diagnosed in patients who developed severe acute COVID-19, but occasionally also in patients who experienced mild or asymptomatic disease. The purpose of this study was to describe the presenting post-COVID-19 characteristics, persistence symptoms and risk factors of COVID-19 patients admitted to and/or visited Maitiga preventive medicine hospital in Tripoli-Libya during the period from November 2020 to November 2021.  <strong>Methods</strong>. A cross sectional study was conducted, and included 935 patients ha

APA, Harvard, Vancouver, ISO, and other styles

22

Zolotovskaia, I. A., P. R. Shatskaia, I. L. Davydkin, and O. A. Shavlovskaya. "Post-COVID-19 asthenic syndrome." Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 121, no. 4 (2021): 25. http://dx.doi.org/10.17116/jnevro202112104125.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Nalbandian, Ani, Kartik Sehgal, Aakriti Gupta, et al. "Post-acute COVID-19 syndrome." Nature Medicine 27, no. 4 (2021): 601–15. http://dx.doi.org/10.1038/s41591-021-01283-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Chocair, Pedro Renato, Precil Diego Miranda de Menezes Neves, Leonardo Victor Barbosa Pereira, et al. "Covid-19 and Metabolic Syndrome." Revista da Associação Médica Brasileira 66, no. 7 (2020): 871–75. http://dx.doi.org/10.1590/1806-9282.66.7.871.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Novaes Matias, Júlia, Gyovanna Sorrentino dos Santos Campanari, Gabriela Achete de Souza, et al. "Metabolic syndrome and COVID-19." AIMS Bioengineering 7, no. 4 (2020): 242–53. http://dx.doi.org/10.3934/bioeng.2020021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Ali, Uzair Akbar, Muhammad Sajjad Sadiq, and Muhammad Jawad Yunus. "Cardiorenal syndrome in COVID-19." BMJ Case Reports 14, no. 4 (2021): e241914. http://dx.doi.org/10.1136/bcr-2021-241914.

Full text

Abstract:

SARS-CoV-2 preferentially targets the human’s lungs, but it can affect multiple organ systems. We report a case of cardiorenal syndrome in a 37-year-old man who had symptoms of fever, myalgia and cough. He tested positive for COVID-19 and presented 5 days later with acute heart failure. Work up was done including echocardiography showing reduced ejection fraction. Later in the hospital course he developed acute renal failure and was treated with intermittent renal replacement therapy. No other definite cause of cardiorenal complications was identified during the course of the disease. A possib

APA, Harvard, Vancouver, ISO, and other styles

27

Rissardo, JamirPitton, and AnaLetícia Fornari Caprara. "Post-COVID-19 neurological syndrome." Santosh University Journal of Health Sciences 8, no. 1 (2022): 74. http://dx.doi.org/10.4103/sujhs.sujhs_6_22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Ali Shah, Syed Zulfiquar, Ikram Din Ujjan, and Naveed Aslam Lashari. "Post-Acute Covid-19 Syndrome." Pakistan Journal of Medical and Health Sciences 15, no. 5 (2021): 891–92. http://dx.doi.org/10.53350/pjmhs21155891.

Full text

Abstract:

The coronaviruses (CoVs) belongs to the subgroup Orthocoronavirinae in the family Coronaviridae, Order Nidovirales.1 During 2002, the China reports first outbreak of SARS quickly spread worldwide, leads to approximately 11% fatality rate while during 2012;2 Middle East Respiratory Syndrome (MERS) originates in Saudi Arabia followed by its spread worldwide with 37% mortality.3 During December 2019, an pneumonia of unknown etiology has been detected in vast majority of patients resides in Wuhan City, Central China and Hubei Province.4 The Genomic research has been identified that this pneumonia

APA, Harvard, Vancouver, ISO, and other styles

29

Gasecka, Aleksandra, Michał Pruc, Katarzyna Kukula, et al. "Post-COVID-19 heart syndrome." Cardiology Journal 28, no. 2 (2021): 353–54. http://dx.doi.org/10.5603/cj.a2021.0028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Polushin, Yu S., E. G. Gavrilova, I. V. Shlyk, S. V. Lapin, and О. Yu Tkachenko. "Catastrophic antiphospholipid COVID-19 syndrome." Messenger of ANESTHESIOLOGY AND RESUSCITATION 18, no. 1 (2021): 17–26. http://dx.doi.org/10.21292/2078-5658-2021-18-1-17-26.

Full text

Abstract:

Thrombophilia, as well as multiple organ dysfunction, are typical manifestations of the severe new coronavirus infection that closely resemble the clinical signs of catastrophic antiphospholipid syndrome (CAPS). The objective: to assess whether catastrophic antiphospholipid syndrome is an essential manifestation of severe forms of COVID-19.Subjects and methods. 45 patients diagnosed with the new coronavirus infection (SARS-CoV-2) and a severe course of viral pneumonia (more than 3 points on the NEWS score by the admission, CT 3-4, oxygenation index below 100, the need for at least high-flow ox

APA, Harvard, Vancouver, ISO, and other styles

31

Chaabouni, H., F. Smaoui, K. Mnif, et al. "COVID-19 and metabolic syndrome." Metabolism 128 (March 2022): 155066. http://dx.doi.org/10.1016/j.metabol.2021.155066.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Montani, David, Laurent Savale, Nicolas Noel, et al. "Post-acute COVID-19 syndrome." European Respiratory Review 31, no. 163 (2022): 210185. http://dx.doi.org/10.1183/16000617.0185-2021.

Full text

Abstract:

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19) pandemic that has resulted in millions of deaths and a major strain on health systems worldwide. Medical treatments for COVID-19 (anticoagulants, corticosteroids, anti-inflammatory drugs, oxygenation therapy and ventilation) and vaccination have improved patient outcomes. The majority of patients will recover spontaneously or after acute-phase management, but clinicians are now faced with long-term complications of COVID-19 including a large variety of symptoms

APA, Harvard, Vancouver, ISO, and other styles

33

Wu, Henry H. L., Varinder S. Athwal, Philip A. Kalra, and Rajkumar Chinnadurai. "COVID-19 and hepatorenal syndrome." World Journal of Gastroenterology 28, no. 39 (2022): 5666–78. http://dx.doi.org/10.3748/wjg.v28.i39.5666.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Callea, Michele, Francisco Cammarata‐Scalisi, Angela Galeotti, Alberto Villani, and Diletta Valentini. "COVID‐19 and Down syndrome." Acta Paediatrica 109, no. 9 (2020): 1901–2. http://dx.doi.org/10.1111/apa.15409.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Yanai, Hidekatsu. "Metabolic Syndrome and COVID-19." Cardiology Research 11, no. 6 (2020): 360–65. http://dx.doi.org/10.14740/cr1181.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Wiwanitkit, Viroj. "Covid-19 and Kawasaki syndrome." Cardiology in the Young 30, no. 9 (2020): 1372. http://dx.doi.org/10.1017/s1047951120001894.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Lima, Ricardo, Célio Cortinhas Filho, Carlos Martins Ferreira Filho, et al. "Hemophagocytic syndrome and COVID-19." Respiratory Medicine Case Reports 31 (2020): 101162. http://dx.doi.org/10.1016/j.rmcr.2020.101162.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Voruz, Philippe, Isabele Jacot De Alcântara, Alexandre Cionca, Anthony Nuber-Champier, Frédéric Assal, and Julie Anne Peron. "Syndrome post-Covid-19 neuropsychologique." Revue Médicale Suisse 19, no. 824 (2023): 800–802. http://dx.doi.org/10.53738/revmed.2023.19.824.800.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Sahu, Dipit, and Tushar Agrawal. "Is it the COVID-19 happy hypoxia syndrome or the COVID 19 infodemic syndrome?" Diabetes & Metabolic Syndrome: Clinical Research & Reviews 14, no. 5 (2020): 1399. http://dx.doi.org/10.1016/j.dsx.2020.07.038.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Agakhani, Nader, and Fariba Hosseinzadegan. "The Pandemic Paradox: Concurrence of Covid-19 and Metabolic Syndrome." Journal of Advances in Medical and Biomedical Research 31, no. 144 (2022): 107–8. https://doi.org/10.30699/jambs.31.144.107.

Full text

Abstract:

<strong>Abstract:</strong>    The health-care system should be ready to deal with a large number of COVID-19 patients who may require critical care. Patients with severe consequences should have well-rehearsed and structured protocols for quick identification, isolation, triage, and care plans. The higher incidence of metabolic syndrome combined with COVID-19 shows that concurrence of these two disorders, as well as the therapeutic and care issues they cause, should be thoroughly investigated to improve defense against disease along its course and more caution and special supportive

APA, Harvard, Vancouver, ISO, and other styles

41

Rao, Nagaraj N. "CHALLENGING COVID-19." INDIAN DRUGS 57, no. 02 (2020): 5–6. http://dx.doi.org/10.53879/id.57.02.p0005.

Full text

Abstract:

Dear Reader, Coronaviruses are a large family of zoonotic viruses, that is, the virus is transmitted from animals to humans. Although several common human coronaviruses are known, and usually lead upon infection to mild to moderate upper-respiratory tract illnesses, some coronaviruses cause epidemics. Severe Acute Respratory Syndrome (SARS-CoV) erupted in February 2003 following transmission from civet cats to humans. Middle East Respiratory Syndrome (MERS-CoV) surfaced in April 2012 following transmission from dromedary camels to humans. However, both these epidemics pale into insignificance

APA, Harvard, Vancouver, ISO, and other styles

42

Apsari Dewi, Ni Putu Rani, and Anak Agung Gde Upeksha. "Post-Acute COVID-19 Syndrome after a Critical COVID-19: A Case Report." International Journal of Science and Healthcare Research 7, no. 1 (2022): 276–83. http://dx.doi.org/10.52403/ijshr.20220141.

Full text

Abstract:

Introduction: The COVID-19 pandemic has caused many impacts in health, economic and social aspect worldwide. Infection of SARS-CoV-2 affects many organ systems. Post-COVID-19 syndrome is a condition when some of those infected with SARS-CoV-2 are complaining symptoms that persist for weeks to months even the PCR was negative. Case Illustrations: We present a case of post-acute COVID-19 syndrome in a 59 years old man with persistent respiratory symptoms for 3 months since the onset of a critical COVID-19. He was admitted to the hospital with critical COVID-19 which he received treatment for COV

APA, Harvard, Vancouver, ISO, and other styles

43

Halder, Susmita. "Cognitive Status in COVID-19 Survivors with Metabolic Syndrome." Series of Endocrinology, Diabetes and Metabolism 3, no. 2 (2021): 33–38. http://dx.doi.org/10.54178/jsedmv3i2001.

Full text

Abstract:

In the current COVID-19 pandemic, co-morbid metabolic syndromes are identified as important risk factors. The presence of metabolic syndrome not only increases mortality rate and probability of hospitalization but is also predicted to have a long-term impact on cognition. A decline in cognitive functioning and functional abilities can be seen in the COVID-19 survivors and it became accelerated by metabolic syndromes that include hypertension, diabetes mellitus, low HDL cholesterol, abdominal obesity, etc. In the present study, it was aimed to explore the cognitive status in COVID-19 survivors

APA, Harvard, Vancouver, ISO, and other styles

44

Simonetti, Alessio, Evelina Bernardi, Stella Margoni, et al. "Mixed Depression in the Post-COVID-19 Syndrome: Correlation between Excitatory Symptoms in Depression and Physical Burden after COVID-19." Brain Sciences 13, no. 4 (2023): 688. http://dx.doi.org/10.3390/brainsci13040688.

Full text

Abstract:

The relationship between depression and post-COVID-19 disease syndrome (post-COVID-19 syndrome) is established. Nevertheless, few studies have investigated the association between post-COVID-19 syndrome and mixed depression, i.e., a specific sub-form of depression characterized by high level of excitatory symptoms. Aims of the present study are: (a) to compare the post-COVID-19 syndrome’s burden in depressed and non-depressed patients, and (b) to investigate the correlation between post-COVID-19 syndrome’s burden and the severity of mixed depression. One thousand and forty six (n = 1460) subje

APA, Harvard, Vancouver, ISO, and other styles

45

Eliyas, Andri, Endang Rochyadi, and Imas Diana Aprilia. "Post-COVID Syndrome: Impact, Investigation Strategies and New Treatment Methods for Students with Disabilities." Proceeding of International Conference on Special Education in South East Asia Region 2, no. 1 (2023): 96–117. http://dx.doi.org/10.57142/picsar.v2i1.71.

Full text

Abstract:

The COVID-19 pandemic has affected people with disabilities in a number of ways, including the development of post-COVID syndromes. Post-COVID syndrome is a condition that affects individuals who have recovered from COVID-19 but continue to experience a variety of symptoms, such as fatigue, shortness of breath and cognitive impairment. This article examines the impact of post-COVID syndrome on students with disabilities and reveals new investigations and treatment methods for post-COVID syndrome. This study uses the literature review method. This study found that post-COVID syndrome can signif

APA, Harvard, Vancouver, ISO, and other styles

46

Sugraliyev, Akhmetzhan, and Рlinio Cirillo. "Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome. Prevention of venous thromboembolism in patients with COVID-19." Journal "Medicine" 3-4, no. 213-214 (2020): 2–7. http://dx.doi.org/10.31082/1728-452x-2020-213-214-3-4-2-7.

Full text

Abstract:

In this review, the authors describe the new concept of MicroCLOTS (microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome) - proposed by Italian multidisciplinary team headed by Ciceri F, et al. as the cause of atypical acute respiratory distress syndrome. Ciceri F, etal. hypothesise that, in predisposed individuals, alveolar viral damage is followed by an inflammatory reaction and by microvascular pulmonary thrombosis. This progressive endothelial thromboinflammatory syndrome may also involve the microvascular bed of the brain and other vital organs, leading to multiple

APA, Harvard, Vancouver, ISO, and other styles

47

Đenić, Aleksandar. "Similarities and differences of cardiovascular complications of COVID-19 infection and COVID-19 vaccination." Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma 27, no. 84 (2022): 69–89. http://dx.doi.org/10.5937/mgiszm2284069q.

Full text

Abstract:

COVID-19 patients may experience with a wide range of cardiovascular complications during infection: obstructive and non-obstructive coronary artery disease-acute coronary syndrome (myocardial infarction type 1 and type 2), arterial or venous thromboembolic diseases, myocarditis, pericarditis, pericardial effusion, stress cardiomyopathy (Takotsubo syndrome), arrhythmias, acute heart failure, shock and sudden cardiac death (cardiac arrest). Cardiovascular complications that may occur after COVID-19 vaccination are: myocarditis, pericarditis, thromboembolic events, hypertension, acute coronary s

APA, Harvard, Vancouver, ISO, and other styles

48

Lakshmi, S* Shehna S. Vimal S. Midhu GV Shiny DV Sreelekshmi S. Reshmi R. and Abi SA. "Covid-19 Pandemic-Insights and Challenges." Journal of Biomedical Research & Environmental Sciences 1, no. 4 (2020): 070–87. https://doi.org/10.37871/jels1123.

Full text

Abstract:

The 2019 Novel Coronavirus (2019-nCoV) outbreak affected a large number of deaths with millions of confirmed cases worldwide. Coronavirus Disease (COVID-19) is associated with respiratory illness that lead to severe pneumonia and Acute Respiratory Distress Syndrome (ARDS). Although related to the Severe Acute Respiratory Syndrome (SARS) and the Middle East Respiratory Syndrome (MERS), Covid-19 shows some unique pathogenetic, epidemiological and clinical features. On the basis of the phylogenetic relationship as well as genomic structures, the Covid-19 belongs to genera Betacoronavirus. Human B

APA, Harvard, Vancouver, ISO, and other styles

49

Kosmynina, N. S., I. Yu Avramenko, and O. L. Luchkovska. "COVID-19 in children." CHILD`S HEALTH 16, no. 5 (2021): 351–54. http://dx.doi.org/10.22141/2224-0551.16.5.2021.239714.

Full text

Abstract:

Background. In 2020, a new human coronavirus, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), became a pandemic, causing the disease course from mild symptoms to severe cases. In this article we analyze the features of the course of coronavirus disease among children from 3 to 18 years. Materials and methods. Medical records of 69 pediatric inpatients aged 3 to 18 years were analysed. They were hospitalized in the Lviv Regional Children’s Clinical Hospital “OHMATDYT” from April to December 2020 with a diagnosis of coronavirus disease. Laboratory tests for the presence of S

APA, Harvard, Vancouver, ISO, and other styles

50

Glaycy, Celeste Monteiro Gomes, Fontinele Castro de Araújo Atílio, Lima Beserra Bruna, et al. "ESTUDO DE PATOLOGIAS EMERGENTES: A SÍNDROME PÓS-COVID-19." Revistaft 27, no. 120 (2023): 56. https://doi.org/10.5281/zenodo.7782856.

Full text

Abstract:

A pandemia da COVID-19 teve um impacto significativo na saúde pública global desde o seu surgimento no final do ano de 2019. Além dos sintomas agudos da infecção pelo vírus SARS-CoV-2, a pandemia também apresentou um desafio significativo em relação às patologias emergentes após as infecções agudas, como a Síndrome pós-COVID-19. Levando em consideração a alta incidência do surgimento desses sintomas, este artigo tem como objetivo revisar a literatura científica di

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!